This content is machine translated Diabetes Management Type 1 diabetics benefit from additive oral therapy Type 1 diabetics with obesity in whom insulin therapy alone is insufficient for glycemic control may additionally benefit from oral treatment with an SGLT2 inhibitor. Recent study results show good…
View Post 12 min This content is machine translated Venous thromboembolism Risks associated with hormone therapy Venous thromboembolism (VTE) is the third most common cardiovascular disease in Central Europe. They manifest as deep vein thrombosis in about two-thirds of cases and with symptoms of pulmonary embolism… CME-Test
View Post 5 min This content is machine translated Diabetic nephropathy SGLT-2 inhibitor protects heart and kidney also in the real-world setting Type 2 diabetes mellitus (T2DM) significantly increases the risk of cardiovascular and renal diseases [1, 2]. However, SGLT-2 inhibitors not only lower blood glucose levels but also have cardio- and…
View Post 7 min This content is machine translated Testosterone Testosterone substitution in the older man: for whom, when and how? Hypogonadism is a clinical syndrome in which dysfunction in the hypothalamic-pituitary-gonadal axis results in decreased production of testosterone with clinical symptoms of testosterone deficiency. When should substitution take place?
View Post 4 min This content is machine translated Diabetes Cases Intensification of the treatment of type 2 diabetes mellitus In a 63-year-old patient, although glucose metabolic control is quite good, there is still potential for optimizing diabetes management. Thus, with a change in therapy, his pre-existing cardiovascular conditions can…
View Post 4 min This content is machine translated SGLT-2 inhibitors and GLP-1-RA How they can protect against diabetic sequelae In recent years, numerous new glucose-lowering agents have been developed. SGLT-2 inhibitors and GLP-1 receptor agonists have demonstrated cardiovascular and nephroprotective effects in large clinical endpoint studies. The variety of…
View Post 3 min This content is machine translated Diabetes Cases Type 2 diabetes mellitus and advanced renal failure A 73-year-old female patient who has had type 2 diabetes mellitus for 10 years is unhappy with her weight and needs improved glycemic control. However, macronutrient malnutrition combined with advanced…
View Post 2 min This content is machine translated Hypertension Detect changes already in childhood and initiate prevention High blood pressure is the cause of a number of sequelae, such as microvascular retinal changes. Hypertension can already begin in childhood – in most cases undetected. This is to…
View Post 6 min This content is machine translated Diabetes treatment Insulin therapy in type 2 diabetics: an update. The most modern representatives of basal insulins are ultra-long acting and associated with low hypoglycemia rates. Mixed insulin or combination preparations of GLP-1-RA and a long-acting insulin are good alternatives…
View Post 2 min This content is machine translated Heart failure SGLT2 inhibitors improve cardiovascular risk SGLT2 inhibitors are used with great success as antidiabetic agents. However, new study data revealed a positive side effect: the drug group appears to have additional cardioprotective as well as…
View Post 5 min This content is machine translated From symptom to diagnosis Spondylosis hyperostotica – common vertebral change in the elderly. Spondylosis hyperostotica is the most common non-inflammatory disease of the spine, with an age-correlated increase in prevalence. This degenerative spinal disease occurs more frequently in patients with diabetes mellitus and…
